Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Endocrinology Année : 2007

Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.

Résumé

Inflammation is associated with obesity and insulin resistance. Proinflammatory cytokines produced by adipose tissue in obesity could alter insulin signaling and action. Recent studies have shown a relationship between IL-1beta level and metabolic syndrome or type 2 diabetes. However, the ability of IL-1beta to alter insulin signaling and action remains to be explored. We demonstrated that IL-1beta slightly increased Glut 1 translocation and basal glucose uptake in 3T3-L1 adipocytes. Importantly, we found that prolonged IL-1beta treatment reduced the insulin-induced glucose uptake, whereas an acute treatment had no effect. Chronic treatment with IL-1beta slightly decreased the expression of Glut 4 and markedly inhibited its translocation to the plasma membrane in response to insulin. This inhibitory effect was due to a decrease in the amount of insulin receptor substrate (IRS)-1 but not IRS-2 expression in both 3T3-L1 and human adipocytes. The decrease in IRS-1 amount resulted in a reduction in its tyrosine phosphorylation and the alteration of insulin-induced protein kinase B activation and AS160 phosphorylation. Pharmacological inhibition of ERK totally inhibited IL-1beta-induced down-regulation of IRS-1 mRNA. Moreover, IRS-1 protein expression and insulin-induced protein kinase B activation, AS160 phosphorylation, and Glut 4 translocation were partially recovered after treatment with the ERK inhibitor. These results demonstrate that IL-1beta reduces IRS-1 expression at a transcriptional level through a mechanism that is ERK dependent and at a posttranscriptional level independently of ERK activation. By targeting IRS-1, IL-1beta is capable of impairing insulin signaling and action, and could thus participate in concert with other cytokines, in the development of insulin resistance in adipocytes.
Fichier principal
Vignette du fichier
Jager_et_al_EN-06-0692_revised.pdf (247.5 Ko) Télécharger le fichier
fig1.jpeg (125.41 Ko) Télécharger le fichier
fig2.jpeg (162.38 Ko) Télécharger le fichier
fig3.jpeg (200.72 Ko) Télécharger le fichier
fig4.jpeg (119.06 Ko) Télécharger le fichier
fig5.jpeg (146.31 Ko) Télécharger le fichier
fig6.jpeg (155.75 Ko) Télécharger le fichier
fig7.jpeg (178.28 Ko) Télécharger le fichier
fig8.jpeg (120.34 Ko) Télécharger le fichier
fig9.jpeg (119.88 Ko) Télécharger le fichier
Format : Autre
Format : Autre
Format : Autre
Format : Autre
Format : Autre
Format : Autre
Format : Autre
Format : Autre
Format : Autre
Loading...

Dates et versions

inserm-00139856 , version 1 (04-04-2007)

Identifiants

Citer

Jennifer Jager, Thierry Grémeaux, Mireille Cormont, Yannick Le Marchand-Brustel, Jean-François Tanti. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.. Endocrinology, 2007, 148 (1), pp.241-51. ⟨10.1210/en.2006-0692⟩. ⟨inserm-00139856⟩
215 Consultations
774 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More